Harley Street Clinic Launches New Era of Cancer Screening to Aid Early Cancer Detection

Phoenix Hospital Group, one of the UK’s leading private healthcare providers with state-of-the-art hospitals in the Harley Street Medical Area (HSMA), has announced the launch of a new and innovative full-body cancer screening imaging service to help detect cancer in its early stages.

Based at 9 Harley Street – the hospital’s outpatient consulting and imaging department in central London – Phoenix’s ‘Advanced Cancer Screening’ uses an innovative new method of MRI scanning known as Whole Body-Diffusion Weighted Imaging (WB-DWI), a non-invasive technique developed from years of clinical research with the aim of diagnosing cancer, much earlier in apparently healthy people.

Phoenix’s revolutionary scan – which takes just 45 mins – is designed to deliver a new era of cancer screening, making it possible to diagnose asymptomatic tumours, including those that are not usually the target of conventional screening programmes, thus helping to tackle this important challenge.

It also works by scanning areas which are not normally screened for such as the bladder, kidney, non-Hodgkin lymphoma, liver and pancreas – allowing radiologists to detect cancer lesions small enough to provide an effective early diagnosis.

Prof Anwar Padhani said: “We are delighted to introduce our new Advanced Cancer Screening which is focused on detecting asymptomatic tumours in clients as early as possible, which as we all know is so important when it comes to giving diagnosed patients the best chance they can have for successful treatment. We know that early diagnosis is key to tackling this challenge, and we are pleased to offer clients a new way to access this.”

Phoenix Hospital Group’s Advanced Cancer Screening is designed to provide a new non-invasive technique to detect cancer earlier. Like all MRI scans, which work by mapping the body using magnetic fields, the scan brings an important benefit as it does not involve any radiation, which is used in CT scans or x-rays. We know that unnecessary radiation exposure can increase the risk of developing cancer in later life.

A recent patient said: “Like many people, the pandemic has made me more conscious of my health. I have a history of cancer in my family, and I was keen to have a thorough check over. My doctor told me about the Advanced Cancer Screening programme at 9 Harley Street, so I booked myself an appointment. The scan lasted 45 minutes and the whole process was easy. I didn’t have to fast, didn’t need any injections, and I could head off home straight afterward with no side effects.

“I was emailed a very thorough report a couple of days later and had a follow-up virtual consultation with the radiologist who explained everything in detail, which was very reassuring. The report was then sent onto my GP for their records. Today I feel so much more comfortable and in control of my health.”

Hot this week

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution